Chung Yealin, de Greeff Annemarie, Shennan Andrew
Maternal & Fetal Research Unit, King's College London, London, UK.
Hypertens Pregnancy. 2009;28(3):348-59. doi: 10.1080/10641950802601286.
To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.
Device accuracy was assessed according to the British Hypertension Society protocol in 45 pregnant women, including 15 with preeclampsia. Twenty-one high-risk pregnant women used the device in addition to their antenatal care.
The device achieved a mean difference +/- SD of 0.4 +/- 7.3/-0.4 +/- 5.5 mmHg (pregnancy) and -2.6 +/- 7.0/0.8 +/- 4.4 mmHg (preeclampsia) for systolic/diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.
The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
评估一种新型家用血压监测设备在高危妊娠中的准确性及患者依从性。
根据英国高血压学会方案，对45名孕妇（包括15名先兆子痫患者）的设备准确性进行评估。21名高危孕妇在接受产前护理的同时使用该设备。
该设备在收缩压/舒张压方面，孕期的平均差值±标准差为0.4±7.3/-0.4±5.5 mmHg，先兆子痫患者为-2.6±7.0/0.8±4.4 mmHg。81%的女性每天至少测量6次，所有女性每周至少测量2次。
Microlife WatchBP Home设备在孕期使用准确，可提高依从性患者的监测水平。
